Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Current Opinion in Genetics & Development|April 23, 2013
How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approachesBrunhilde Wirth, Lutz Garbes, Markus RiesslandCurrent Pharmaceutical Design|March 2, 2013
Histone acetylation as a potential therapeutic target in motor neuron degenerative diseasesLutz Garbes, Markus Riessland, Brunhilde WirthHuman Genetics|January 4, 2008
Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophyLars Brichta, Lutz Garbes, Maria Jedrzejowska, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 3, 2013
A nonclassical IFITM5 mutation located in the coding region causes severe osteogenesis imperfecta with prenatal onsetHeike Hoyer-Kuhn, Oliver Semler, Lutz Garbes, et al.Human Molecular Genetics|July 9, 2009
LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproateLutz Garbes, Markus Riessland, Irmgard Hölker, et al.Neuromuscular Disorders : NMD|December 5, 2013
Exome sequencing identifies Laing distal myopathy MYH7 mutation in a Roma family previously diagnosed with distal neuronopathyKatalin Komlósi, Kinga Hadzsiev, Lutz Garbes, et al.Human Molecular Genetics|January 26, 2010
SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophyMarkus Riessland, Bastian Ackermann, Anja Förster, et al.Journal of Child Neurology|December 17, 2013
A paucisymptomatic neuromuscular disease mimicking type III 5q-SMA with complex rearrangements in the SMN geneLaura Nanna Lohkamp, Katja von Au, Hans-Hilmar Goebel, et al.Human Molecular Genetics|October 19, 2012
VPA response in SMA is suppressed by the fatty acid translocase CD36Lutz Garbes, Ludwig Heesen, Irmgard Hölker, et al.Breast Cancer Research : BCR|December 24, 2013
RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer familiesGioia Schnurbein, Jan Hauke, Barbara Wappenschmidt, et al.Pageof 2